Robert Jiang
About Robert Jiang
Robert Jiang is the Associate Director of Statistical Programming at Bristol Myers Squibb, with extensive experience in statistical programming and drug development.
Current Title and Role
Robert Jiang serves as the Associate Director of Statistical Programming at Bristol Myers Squibb. In this role, he oversees and coordinates statistical programming activities, ensuring the accuracy and integrity of statistical analyses for clinical trials. His responsibilities include creating and validating analysis files and TLFs (tables, listings, and figures) for various regulatory submissions such as CSR, DMC, IB, ISS, NDA, sNDA, and MAA.
Career History and Experience
Before joining Bristol Myers Squibb, Robert Jiang held several positions in the field of statistical programming and analytics. He was a Principal Statistical Programmer at MyoKardia in South San Francisco from 2019 to 2021. Prior to that, he worked at Pharmacyclics LLC as a Statistical Programmer III and Statistical/Clinical Programmer II between 2015 and 2019. His diverse experience includes roles as a SAS Programmer at Meta-Xceed, Statistical Programmer at InClin, Inc., and Business Data Analyst and Fund-Raiser at a private biotech startup. Earlier in his career, he served as an Associate Scientist at Gilead Sciences and as a Research Scientist at CV Therapeutics.
Education and Academic Background
Robert Jiang holds an MBA from Golden Gate University, achieved between 2010 and 2012. He also studied Pharmaceutical Chemistry at the University of Illinois at Urbana-Champaign, focusing on breast cancer research. Additionally, he completed a degree in Material Science and Engineering with a minor in Statistics at the University of Science and Technology of China.
Skills and Technical Proficiency
Robert Jiang possesses an extensive skill set in statistical programming and data analysis. He is proficient in Base SAS, SAS/Macros, SAS/STAT, SAS/Graph, SAS/SQL, SAS/ODS, and R. His additional technical skills include MS Office Advanced Excel for Managers, Linux, and Excel VBA. He has developed and implemented SAS macro standardization for ADaM/Efficacy TFL and has a strong foundation in therapeutic areas like Oncology, Cardiovascular & Metabolic Diseases, and Infectious Diseases.
Achievements and Contributions
Throughout his career, Robert Jiang has co-invented five drug candidates that have entered human clinical trials. His work includes developing quantitative approaches to address complex business questions and implementing robust statistical methodologies. In addition to his technical contributions, he has also demonstrated strong people management and project management skills, significantly impacting the biometrics teams he has led.